India’s leading hand specialist, Dr. Vikas Gupta, provides expert diagnosis and surgical treatment for Giant Cell Tumour of the Tendon Sheath — the most common benign soft tissue tumour of the hand and fingers.
Giant Cell Tumour of the Tendon Sheath (GCT-TS) is a benign soft tissue growth arising from the synovial lining of tendon sheaths in the hand and fingers. It is the second most common benign hand tumour after ganglion cysts.
Although benign, GCT-TS can erode bone and cause significant discomfort if left untreated. Surgical excision by an experienced hand specialist is the definitive treatment, and complete removal is essential to minimise the risk of recurrence.
GCT of the tendon sheath most commonly affects the fingers of the dominant hand, particularly the index and middle fingers, and is most frequently seen in adults between 30 and 50 years of age.
From recognizing a suspicious finger lump to knowing when to seek specialist care.
A slow-growing, firm, painless lump near a finger joint or tendon is the classic presentation. It may cause stiffness or limit joint movement.
Ultrasound and MRI are the gold standard imaging tools to assess the size, location, and extent of the tumour before planning surgical excision.
Complete surgical removal under magnification is the definitive treatment. Meticulous excision of all tumour extensions minimises recurrence.
Dr. Vikas Gupta offers meticulous, complete excision of GCT-TS with careful protection of surrounding tendons, nerves, and joint structures to ensure the best functional outcome.
Surgery under loupe magnification or microscope allows complete removal of the tumour and all its extensions from tendon sheaths, joint capsule, and adjacent bone.
GCT-TS has a recurrence rate of 10–20%. Recurrent tumours require careful re-excision, and in rare diffuse cases, adjunctive therapy may be considered.
Recovery after GCT excision is generally straightforward. Most patients regain full finger function within 4–6 weeks with appropriate physiotherapy.
Dr. Vikas Gupta is a Senior Consultant in Hand, Wrist & Shoulder Surgery with over three decades of experience treating hand tumours including GCT of the tendon sheath. His subspecialty training in hand surgery equips him with the precision and expertise required for meticulous tumour excision.
Dr. Gupta performs GCT excisions under magnification, ensuring complete removal of all tumour extensions to achieve the lowest possible recurrence rates while preserving full hand function.
Ultrasound and MRI for accurate tumour characterisation, location mapping, and pre-surgical planning.
Excision under loupe magnification ensures complete tumour removal and minimises injury to adjacent structures.
Day-case surgery with structured rehabilitation to restore full finger and hand function in 4–6 weeks.
Meticulous complete excision technique and regular follow-up to detect and manage any recurrence early.
A finger lump that is growing should always be assessed by a specialist — early excision means a simpler operation and lower recurrence risk.
GCT of the tendon sheath requires complete surgical excision. The earlier you consult, the simpler the procedure. Speak to Dr. Vikas Gupta today.
Comprehensive information about Giant Cell Tumour of the Tendon Sheath — what it is, causes, symptoms, types, risk factors, and how it is diagnosed.
Giant Cell Tumour of the Tendon Sheath (GCT-TS), also called Tenosynovial Giant Cell Tumour (TGCT) — Localized Type, is a benign but locally aggressive soft tissue tumour arising from the synovial lining of tendon sheaths, bursae, or joint capsule in the hand and fingers.
It is the most common benign soft tissue tumour of the hand, and the second most common hand lump overall after ganglion cysts. Despite being benign, GCT-TS can erode adjacent bone in up to 15% of cases and recur after incomplete excision.
The most common benign soft tissue tumour of the hand and fingers
Most common between ages 30 and 50; slight female predominance
Predominantly fingers, especially index and middle finger volar surface
Complete surgical excision is the only definitive treatment
Current evidence suggests GCT-TS is a true neoplasm with clonal proliferation of synoviocytes, though the exact trigger is not fully understood.
Some studies link GCT-TS to previous local trauma or repetitive finger use, though a definitive causal relationship has not been conclusively established.
Some researchers consider GCT-TS as a reactive proliferative disorder of the synovium, triggered by local inflammatory processes within the tendon sheath.
Any new lump near a finger joint or tendon, particularly if slowly enlarging, should be assessed by a hand specialist.
A firm, lobulated, slow-growing lump near a finger joint or tendon — the most common presentation
Reduced range of motion in the adjacent joint as the tumour grows and impinges on structures
Numbness or tingling if the tumour compresses a digital nerve alongside the tendon sheath
Subungual GCT can cause nail deformity, ridging, or discolouration in some cases
Intermittent aching or discomfort, particularly with gripping or direct pressure on the lump
In advanced cases, deep aching pain may indicate cortical bone erosion by the tumour
Your lump has been growing, is causing stiffness, or has been present for more than 3 months — early excision is simpler with lower recurrence risk.
GCT of the tendon sheath is classified based on growth pattern and extent of involvement.
A well-defined, nodular, lobulated mass attached to the tendon sheath. The most common form. Usually less than 3 cm. Excellent prognosis after complete excision.
Less common, more infiltrative growth pattern involving the entire joint synovium or tendon sheath. Higher recurrence rate after excision. May require additional treatment.
Arising within a joint rather than from the tendon sheath. Commonly affects the knee (PVNS), but can occur in finger joints. Requires intra-articular excision or synovectomy.
The classic form arising from the tendon sheath outside the joint, typically on the volar (palm) side of the fingers, most commonly in the index and middle fingers.
Approximately 10–15% of GCT-TS cases show cortical bone erosion on X-ray. This indicates locally aggressive behaviour and requires careful pre-surgical planning including CT evaluation.
Extremely rare (<1%). Malignant transformation may occur in longstanding or recurrent tumours. Characterized by rapid growth, pain, and atypical histological features on biopsy.
Peak incidence in the fourth and fifth decades of life, though it can occur at any age including children.
GCT-TS occurs slightly more frequently in women, with a female-to-male ratio of approximately 1.5:1.
The dominant hand is more commonly affected, suggesting that repetitive use and minor trauma may play a role.
A history of local trauma to the hand or finger may predispose to tumour development in some patients.
People in occupations involving frequent, forceful, or repetitive gripping activities may have increased exposure risk.
Patients with a previously excised GCT-TS have a 10–20% risk of local recurrence, especially with incomplete initial excision.
A hand surgeon assesses the lump’s size, mobility, firmness, transillumination, and relationship to adjacent tendons and joints.
To assess for cortical bone erosion, periosteal reaction, or pressure defects in adjacent bone in advanced or longstanding cases.
First-line imaging: confirms a solid hypoechoic mass with internal vascularity, closely related to the tendon sheath. Helps plan surgical approach.
Low signal on T1 and T2 sequences due to haemosiderin deposition is characteristic of GCT-TS. Essential for assessing extent, bone involvement, and surgical planning.
Definitive diagnosis is made on microscopic examination of the excised specimen, showing characteristic giant cells, foam cells, and haemosiderin-laden macrophages.
Surgical excision under magnification is the definitive treatment for GCT of the tendon sheath — a procedure that demands meticulous technique and specialist hand surgery expertise.
Complete surgical excision is the only definitive treatment for GCT of the tendon sheath. The goal is to remove the tumour entirely, including all extensions into adjacent tendon sheath, joint capsule, or bone, while preserving full function of the finger and hand.
Surgery is typically performed under local or regional (wrist block) anaesthesia as a day-case procedure. Dr. Vikas Gupta operates under loupe magnification to identify and excise all tumour lobules while protecting the digital nerves and flexor tendons.
Incomplete excision is the primary cause of GCT recurrence. Dr. Gupta’s meticulous technique under magnification minimises the risk of leaving residual tumour tissue.
Recurrence affects approximately 10–20% of patients after GCT-TS excision. It is more common with the diffuse type, incomplete initial excision, and when bone erosion was present.
Most recurrent GCT-TS cases are managed with careful re-excision. The surgical approach is guided by pre-operative MRI to map the full extent of recurrent disease before surgery.
The diffuse type carries a higher recurrence rate. In selected cases, systemic targeted therapy (CSF1R inhibitors such as pexidartinib) may be considered alongside or after surgery for unresectable diffuse disease.
In cases with significant cortical bone erosion, curettage of the bone defect is performed alongside tumour excision. CT scanning pre-operatively determines the extent of bony involvement.
Recovery after GCT excision is generally rapid and straightforward with appropriate post-operative care.
Bulky dressing applied. Hand kept elevated to reduce swelling. Light finger movement encouraged from the first day.
Wound review and dressing changes. Suture removal at 10–14 days. Splint may be worn for comfort during activities.
Gentle range-of-motion exercises for all finger joints. Scar management begins after wound healing. Most daily activities resumed.
Progressive grip and pinch strength exercises. Return to most normal work and activities including light manual work.
Full return to all activities including sport and heavy manual work. Regular follow-up continues to monitor for recurrence.
Senior Consultant — Hand, Wrist & Shoulder Surgery | Founder, Hand2Shoulder Clinic
Dr. Vikas Gupta is one of India’s most experienced hand surgeons, with a distinguished career spanning over three decades. He founded the Hand2Shoulder Clinic to provide subspecialty-level care for complex hand conditions including GCT of the tendon sheath, distal radius fractures, carpal tunnel syndrome, and tendon disorders.
His surgical expertise in GCT-TS includes meticulous excision under loupe magnification, careful management of tumours with bone erosion, and re-excision of recurrent disease — all performed with the goal of complete cure and full functional restoration.
Dr. Gupta performs all hand tumour surgeries at a premium facility in New Delhi, offering day-case procedures, rapid recovery, and comprehensive follow-up care to monitor for recurrence.
GCT of Tendon Sheath
Hand & Finger Tumours
Distal Radius Fractures
Carpal Tunnel Syndrome
Tendon Repairs & Transfers
Wrist Arthroscopy
All GCT excisions are performed under loupe magnification, enabling identification and complete removal of all tumour lobules while precisely protecting digital nerves and flexor tendons.
Every patient receives a thorough explanation of their diagnosis, the surgical procedure, the recurrence risk, and the expected recovery timeline before proceeding with treatment.
A structured two-year follow-up programme after GCT excision ensures early detection of any recurrence and prompt re-intervention, giving patients the best possible long-term outcomes.
Expert-written educational content on Giant Cell Tumour of the Tendon Sheath by Dr. Vikas Gupta and the Hand2Shoulder Clinic team.
Send us your details and Dr. Vikas Gupta’s team will respond within 24 hours to schedule your appointment.
All fields marked * are required. We respond within 24 hours.
Your information is kept strictly confidential and used only to respond to your enquiry.